Partners
Expertise Partner: WuXi Biology
WuXi Biology provides a full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and clinical trials. Our world-class discovery platform is backed by more than 3,000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Innovation Partner: Lino Biotech AG
Lino Biotech AG, a Miltenyi Biotec Company, advances drug discovery with its label-free focal Molography platform, enabling real-time, multiplexed biomolecular interaction analysis in complex biological samples like human serum and living cells. By measuring interactions in their native environment, its MACS® Matchmaker system delivers precise kinetic and affinity data, especially for high-throughput DNA-encoded library (DEL) hit validation. From antibody screening to GPCR analysis, we provide high-sensitivity solutions that accelerate therapeutic development with unmatched biological relevance.
Exhibition Partner: Gator Bio
Gator Bio is a Silicon Valley biotech company with a mission to help biopharma scientists gain research insights faster. We fused engineering and science expertise to create novel analytical technologies that achieve better performance and more convenient solutions at a fraction of the cost of existing products. This is the biolayer interferometry solution you've been waiting for.
Event Partner: Curia
Curia is a global Contract Development and Manufacturing Organization with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing to make treatments broadly accessible to patients. Our Small Molecules offering spans discovery to commercial manufacturing and fill-finish services, integrating scientific, process, regulatory and analytical capabilities. Curia’s scalable technologies and dedicated teams advance your program through drug substance and drug product manufacturing.
From curiosity to cure, we are your trusted ally to accelerate life-changing therapeutics. To learn more visit us at https://curiaglobal.com/small-molecules/
Exhibition Partner: SAI Life Sciencegy
Sai Life Sciences is the fastest-growing contract research, development, and manufacturing organisation (CRDMO) among listed Indian peers (in terms of revenue CAGR as well as EBITDA CAGR from FY22 to FY24). As a pure-play, full-service CRDMO, we work with over 280 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.
Over the past 25 years, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. As of March 2024, we had 2845 employees across our facilities in India, UK, USA and Japan.